Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05768399 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The Role of Biomarkers in the Occurrence and Development of Asthma

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial status: Not Yet Recruiting to Recruitingv2 Show 4 more changesShow less
    • Primary completion date: Dec 31, 2023 to Dec 31, 2028
    • Start date changed from estimate of Apr 1, 2023 to Jul 4, 2023
    • Study sites: 0 to 1
    • Study completion date: Dec 31, 2024 to Dec 31, 2029
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
To study the expression level of biomarkers such as GITRL in peripheral blood of children with asthma and analyze their correlation with the severity of asthma. To study the predictive value of biomarkers level for the occurrence and development of asthma. And to provide supplementary detection means and predictive indicators for the diagnosis of asthma and the severity of asthma.
Trial Details
NCT Number NCT05768399
Lead Sponsor Children's Hospital of Chongqing Medical University
Conditions
(from sponsor)		 Asthma in Children
Related terms Asthma
Enrollment 2 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov